Table 3.
Discriminatory antibodies for CD8+ T cellsa
| Discriminatory Antibody | Up(+)/Down(-) | P Value |
| BDL vs. NEG | ||
| CD57 | + | 0.0272 |
| CD45RO | + | 0.0307 |
| HLA-DR | + | 0.0315 |
| CD95 | + | 0.0538 |
| LTNP vs. NEG | ||
| HLA-DR | + | 0.0039 |
| CD11c | + | 0.0072 |
| CD38 | + | 0.0219 |
| CD27 PH | - | 0.0310 |
| CD95 | + | 0.0545 |
| CD57 | + | 0.0591 |
| CD16 | + | 0.0631 |
| CD212b1 | + | 0.0745 |
| CD45RO | + | 0.0953 |
| VIR vs. NEG | ||
| CD57 | + | 0.0006 |
| CD45RO | + | 0.0067 |
| CD38 | + | 0.0091 |
| CD95 | + | 0.0091 |
| HLA-DR | + | 0.0190 |
| CD9 | - | 0.0268 |
| CD212b1 | + | 0.0776 |
| BDL vs. LTNP | ||
| CD11c | - | 0.0049 |
| CD16 | - | 0.0093 |
| CD56 | - | 0.0871 |
| VIR vs. LTNP | ||
| CD11c | - | 0.0017 |
| CD56 | - | 0.0121 |
| CD16 | - | 0.0308 |
| CD27PH | + | 0.0585 |
| CD9 | - | 0.0862 |
| VIR vs. BDL | ||
| CD38 | + | 0.0124 |
aSix paired comparisons of CD markers on CD8+ cells providing significant discrimination between patient groups, with relative changes in CD antigen binding in the former vs. the latter denoted by "+" and "-" to indicate increase and decrease, respectively. Antigens that did not achieve statistical significance (p > 0.05) but have been previously reported in HIV disease context or have been found to be significant in other pair comparisons are also shown in italic.